Human gene therapy for hemophilia
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Guidance for industry
- Contributor(s):
- United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Biologics Evaluation and Research (U.S.), issuing body.
- Publication:
- Silver Spring, MD : Center for Biologics Evaluation and Research, January 2020
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Genetic Therapy Hemophilia A -- drug therapy Hemophilia B -- drug therapy Clinical Trials as Topic Drug Evaluation, Preclinical Factor VIII -- therapeutic use Factor IX -- therapeutic use United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Genre(s):
- Technical Report
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (i, 15 pages)).
- NLM Unique ID:
- 101767661 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101767661